Craniopharyngioma: a case report and comparative galectin histochemical analysis

. 2002 Mar-Apr ; 34 (3-4) : 117-22.

Jazyk angličtina Země Nizozemsko Médium print

Typ dokumentu kazuistiky, srovnávací studie, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid12495217

Craniopharyngioma is a rare benign tumour originating from Rathke's pouch. This paper reports a tumour case studied with a set of markers defining protein-carbohydrate recognition. Expression of endogenous lectins and their reactive glycoligands is under differentiation-dependent control in many cell types. These parameters can be related to the degree of cell differentiation in tumours. Therefore, the expression patterns of endogenous lectins, namely galectins-1, -3, and -7, in the craniopharyngioma case were determined. Galectins-1 and -3 were also used to reveal glycoconjugates in cells and extracellular matrices, an approach that has heretofore relied largely on plant lectins. The staining pattern of craniopharyngioma is compared with that of two other types of ectodermally derived tumours, namely basal and squamous cell carcinomas. Clusters of polygonal and flattened cells with morphological characteristics of differentiated cells in the craniopharyngioma and the majority of poorly differentiated cells in squamous cell carcinomas were reactive with galectin-3. No binding of this probe was observed in cells of basal cell carcinomas and the majority of craniopharyngioma cells. In view of the lack of accessible binding in the basal layer of normal squamous epithelia where proliferative cells (including stem cells) are located, galectin-3 binding could be used to distinguish basal from suprabasal cells of squamous epithelial cells.

Zobrazit více v PubMed

Am J Clin Pathol. 1999 May;111(5):623-31 PubMed

Int J Dev Biol. 1999 May;43(3):245-54 PubMed

Am J Clin Pathol. 1999 Aug;112(2):194-203 PubMed

Neuropathol Appl Neurobiol. 1999 Aug;25(4):319-30 PubMed

J Cancer Res Clin Oncol. 1999 Aug-Sep;125(8-9):461-74 PubMed

Cancer. 1999 Dec 1;86(11):2353-63 PubMed

Int J Mol Med. 2000 Apr;5(4):369-72 PubMed

Folia Biol (Praha). 1999;45(4):157-62 PubMed

J Biol Chem. 2000 Jun 2;275(22):16730-7 PubMed

East Mediterr Health J. 1999 May;5(3):490-502 PubMed

Naturwissenschaften. 2000 Mar;87(3):108-21 PubMed

Otolaryngol Head Neck Surg. 2000 Jun;122(6):834-41 PubMed

Arch Pathol Lab Med. 2000 Sep;124(9):1356-60 PubMed

Virchows Arch. 2000 Sep;437(3):284-92 PubMed

Cells Tissues Organs. 2001;168(1-2):5-23 PubMed

Anat Histol Embryol. 2001 Feb;30(1):3-31 PubMed

Int J Oncol. 2001 Jul;19(1):59-64 PubMed

J Biol Chem. 2001 Sep 21;276(38):35917-23 PubMed

J Biol Chem. 2002 Feb 1;277(5):3487-97 PubMed

Chembiochem. 2001 Nov 5;2(11):822-30 PubMed

Leukemia. 2002 May;16(5):840-5 PubMed

Cells Tissues Organs. 2002;171(2-3):135-44 PubMed

Biochim Biophys Acta. 2002 Sep 19;1572(2-3):285-93 PubMed

J Cell Biol. 1991 Nov;115(3):829-41 PubMed

J Craniofac Genet Dev Biol. 1985;5(1):89-104 PubMed

Cancer Invest. 1987;5(1):39-46 PubMed

No To Shinkei. 1994 Mar;46(3):271-6 PubMed

Int J Dev Biol. 1995 Jun;39(3):459-68 PubMed

Noshuyo Byori. 1993;10(2):131-4 PubMed

Exp Dermatol. 1994 Feb;3(1):9-16 PubMed

Biochemistry. 1996 May 14;35(19):6073-9 PubMed

Proc Natl Acad Sci U S A. 1996 Jun 25;93(13):6737-42 PubMed

AJNR Am J Neuroradiol. 1996 Sep;17(8):1427-39 PubMed

Eur J Biochem. 1997 Feb 1;243(3):543-76 PubMed

Histopathology. 1997 Feb;30(2):172-6 PubMed

Clin Neuropathol. 1997 Mar-Apr;16(2):103-6 PubMed

Cancer Invest. 1997;15(5):454-64 PubMed

Cancer Res. 1997 Dec 1;57(23):5272-6 PubMed

Eur J Oral Sci. 1998 Apr;106(2 Pt 1):667-70 PubMed

Differentiation. 1998 Jul;63(3):159-68 PubMed

Acta Anat (Basel). 1998;161(1-4):162-79 PubMed

J Immunol. 1999 Jan 15;162(2):799-806 PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...